Table 4

Comparison of outcomes after MT in patients with and without medical contraindications for IVT

OutcomeMT
(N=21)
IVT +MT
(N=53)
p Value
Duration of endovascular procedure, min, median (IQR)69 (47–117)60 (40–84)0.27
Time from symptom onset to recanalization, min, median (IQR)259 (215– 328)325 (280–390)0.018
NIHSS at 24 hours, median (IQR)8 (5–16)5 (2–13)0.15
NIHSS at 7 days, median (IQR)5 (2–16)3 (1–10)0.2
Significant improvement at 7 days, N (%)12 (57)33 (62)0.68
NIHSS score 0–1 7 days, N (%)5 (24)19 (36)0.31
Mortality within 7 days, N (%)1 (5)2 (4)0.9
Symptomatic intracranial hemorrhage, N (%)0 (0)3 (6)0.54
Any intracranial hemorrhage, N (%)2 (10)13 (25)0.2
 HI10 (0)4 (7.5)
 HI21 (5)3 (6)
 PH11 (5)2 (4)
 PH20 (0)4 (7.5)
Independence (mRS 0–2) at 3 months, N (%)9 (43)36 (68)0.046
Mortality at 3 months, N (%)3 (14)2 (4)0.13
Death or dependence at 3 months, N (%)12 (57)17 (32)0.04
  • HI, hemorrhagic infarction; IVT, IV thrombolysis; mRS, modified Rankin Scale; MT, mechanical thrombectomy; NIHSS, National Institutes of Health Stroke Scale; PH, parenchymal hematoma.